BMS Japan to Integrate Celgene Next Year, HQ Relocation Planned in H1 2022: Chief

Jean-Christophe Barland, President and CEO of Bristol-Myers Squibb K.K. and Celgene K.K. The Japan arms of Bristol Myers Squibb and Celgene are scheduled to integrate in 2021, and plan to relocate their headquarters in the first half of 2022, Jean-Christophe...read more